Key Record Dates
| ClinicalTrials.gov Identifier: | NCT02028507 |
|---|---|
| Brief Title: | Phase III Palbociclib With Endocrine Therapy vs. Capecitabine in HR+/HER2- MBC With Resistance to Aromatase Inhibitors (PEARL) |
| First Submitted : | January 2, 2014 |
| First Submitted that Met QC Criteria : | January 3, 2014 |
| First Posted : | January 7, 2014 (Estimate) |
| Last Update Submitted that Met QC Criteria : | January 18, 2021 |
| Last Update Posted : | January 20, 2021 |